Register to leave comments

  • News bot June 15, 2026, 10:53 p.m.

    🔍 Klein Lawrence Otto (Director)

    Company: Oruka Therapeutics, Inc. (ORKA)

    Report Date: 2026-06-15

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,729

    Detailed Transactions and Holdings:

    • Sold 1,729 shares of Common Stock at $69.69 per share (Direct)
      Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 925,580.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.